Iraq’s Ministry of Health and Jamjoom Pharma Sign a Cooperation Protocol to launch ‘Ishraqa’ Glaucoma Awareness Campaign

Iraq’s Ministry of Health and Jamjoom Pharma Sign a Cooperation Protocol to launch ‘Ishraqa’ Glaucoma Awareness Campaign Baghdad, Iraq, October 29, 2025 – In a significant step towards advancing public health and preventive eye care in Iraq, the Iraqi Ministry of Health and Jamjoom Pharma have signed a cooperation protocol to launch the national campaign…

Lifera and Jamjoom Pharma Launch Strategic Joint Venture to Power Saudi Arabia’s Biopharma Future

Lifera and Jamjoom Pharma Launch Strategic Joint Venture to Power Saudi Arabia’s Biopharma Future RIYADH, Saudi Arabia, October 27, 2025 – Lifera, A PIF Company, focused on the localization and expansion of Saudi Arabia’s biopharmaceutical sector, announced at the Global Health Exhibition (GHE) a potential Joint Venture (JV) with Jamjoom Pharma, one of the Kingdom’s…

Jamjoom Pharma and Iraqi Dermatology Society Sign MoU to Transform Skin Health Awareness

Jamjoom Pharma and Iraqi Dermatology Society Sign MoU to Transform Skin Health Awareness Baghdad, Iraq – 25 September, 2025 – The Iraqi Dermatology Society and Jamjoom Pharma have signed a Memorandum of Understanding (MoU) to collaborate on a nationwide awareness initiative, ECZPLORE, aiming at supporting patients, caregivers, and healthcare professionals in the fight against eczema…

Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA

Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA Jeddah, Saudi Arabia –15 September, 2025 – Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma), one of the fastest-growing pharmaceutical companies in the Middle East and Africa, announced the signing of a strategic commercialization agreement with Bio-Thera Solutions, Ltd. (688177:SH), a global biopharmaceutical company…

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA JEDDAH, July 30, 2025 – Jamjoom Pharma, a leading Saudi pharmaceutical organization committed to enhancing the quality of life through the development, manufacturing, and distribution of high-quality medicines and consumer healthcare products across MEA, and Althera Laboratories, a company dedicated to developing and commercializing…